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Abstract 
According to the cancer research UK (2017), 14.1 million new cases of cancer were 
registered leading to the death of 8.2 million patients in 2012. It is estimated that by 2030, 
the incidence rate of cancer will rise to 23.6 million cases per year. (2017). Skin cancer 
melanoma is the 5th most common cancer in the UK as per Cancer Research UK (2015).  
This study focuses on skin cancer melanoma due to its increasing mortality rate. This 
study aims to screen medicinal plants from across the world against skin cancer 
melanoma.  26 medicinal plants were extracted with chloroform and methanol. 52 extracts 
of 26 plants were screened for anti-proliferation against human skin cancer melanoma 
cell line A375 and mice skin cancer melanoma cell line B16, using a colorimetric assay 
MTT. Plants like Horsetail and Melissa officinalis have shown significant results in 
decrease of cell viability. Melissa officinalis Lemon Balm has majorly shown a significant 
decrease in % cell viability in methanol extracts (IC50= 0.39µg/ml) in comparison to 
positive control (IC50= 0.65µg/ml) on B16 cell line. Equisetum arvense Horsetail shows 
less than 25% cell viability across all the extracts and cell lines. This study unveils 
interesting anticancer activity of some medicinal plants from across the world.  
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Chapter 1: Introduction 
Cancer has emerged as a fatal disease worldwide, increasing demand for cure and 
treatment for cancer.  According to World Health Organisation (2018), one in three cancer 
diagnosed is skin cancer. Around 232,000 people were diagnosed with skin cancer 
melanoma in 2012 as per Cancer Research UK (2018). 
1.1 Cancer  
Cancer is defined as the disease caused by uncontrolled division of abnormal cells leading 
to the formation of a tumour (National Cancer Institute, 2018). It is the malfunctioning of 
the cell cycle where cells keep growing and dividing without dying leading to the 
formation of a tumour mass in parts of the body. Failure to treat or prevent the spread of 
cancerous tumour which eventually leads to death. Several factors are responsible to 
cause the deadly disease including infectious organisms, unhealthy diet, environmental 
toxins, genetic mutations, immune conditions and hormones (Asadujjaman and Mishuk, 
2013). 
1.1.1 Types of cancer 
There are many types of cancer that are sub divided into 6 categories (Table 1 adapted 
from; Asadujjaman and Mishuk, 2013) 
Table 1.1: Different types of cancer 
Category  Types  Examples 
Carcinoma Adenocarcinoma 
Squamous cell carcinoma 
Transitional cell carcinoma 
Clear cell carcinoma 
(CancerCenter.com, 2018) 
Lung, colon, breast 
Head neck, anal, skin 
Bladder 
Renal (CancerCenter.com, 
2018) 
Leukaemia Myelogenous or granulocytic 
Lymphatic, lymphoblastic 
(CancerCenter.com, 2018) 
Myeloid and granulocytes 
Lymphoid and lymphocytic 
(CancerCenter.com, 2018) 
Lymphoma Hodgkin lymphoma 
Non-Hodgkin lymphoma 
(Asadujjaman and Mishuk, 
2013) 
Stomach, brain, breast 
(Asadujjaman and Mishuk, 
2013) 
 
Myeloma  Plasma cells in bone 
marrow (Asadujjaman and 
Mishuk, 2013) 
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(Keyword-suggest-
tool.com, 2018) 
Mixed types Adenosquamous carcinoma 
Mixed mesodermal tumour 
Carcinosarcoma (Asadujjaman 
and Mishuk, 2013) 
Breast, Lung, Colon, 
Prostate (Asadujjaman and 
Mishuk, 2013) 
Sarcoma Osteosarcoma (bono sarcoma) 
Soft tissue sarcoma 
(CancerCenter.com, 2018) 
 
Bone 
Smooth muscles, 
connective tissues, blood 
vessels (Asadujjaman and 
Mishuk, 2013) 
 
1.2 Carcinoma: Skin Cancer 
Skin Cancer is the most common type of cancer in the world (Craythorne and Al-Niami, 
2017). As of 2015, 15400 new melanoma skin cancer cases were registered accounting 
for 8100 in men and 7800 in women. (Cancer Research UK, 2018). There are 2400 
melanoma skin cancer deaths in UK, as of 2016 as per Cancer Research UK.  
1.2.1 Types of Skin Cancer 
Skin cancer consist of two categories; non melanoma skin cancer (derived from epidermal 
cells) and melanoma skin cancer (derived from melanocytes) accounting for 95% of skin 
cancer types. (Craythorne and Al-Niami, 2017). Figure 1 below shows the different 
categories and sub categories of skin cancer.   
 
Figure 1.1: Different types of Skin Cancer (Simões, Sousa and Pais, 2015) 
Skin Cancer
Melanoma
Superficial 
spreading 
Melanoma
Nodular 
Melanoma
Lentigo Maligna 
Melanoma
Acral Melanoma
Non Melanoma
Basal Cell 
Carcinoma
Squamous Cell 
Carcinoma 
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1.2.1.1 Non Melanoma Skin Cancer 
Non melanoma skin cancer (NMSC) is the most common form of cancer. There are two 
types of NSMC; basal cell carcinoma accounting for 75% cases of NSMC and squamous 
cell carcinoma accounting for 25% (Samarasinghe and Madan, 2012) 
1.2.1.2 Melanoma Skin Cancer 
Melanoma Skin cancer is the deadliest type of skin cancer. Melanoma skin cancer is 
further divided into four types; superficial spreading melanoma (a slow growing 
melanoma), nodular melanoma (fast growing melanoma), lentigo malignant melanoma 
(affects areas of skin that has been extensively exposed to sun, generally of older people) 
and acral melanoma (occurs on soles of feet and palms of hand).  (Skin cancer: Types, 
diagnosis and prevention, 2013) 
Malignant melanoma occurs only in 4% of the population yet it causes 65% of skin cancer 
related deaths (Porter et al 2011) Malignant melanoma originates from epidermal 
melanocytes and is induced through various mechanism such as suppression of immune 
system of the skin, damage of melanocyte and induction of melanocyte cell division 
(Cummins DL, 2006). Melanocyte cells produces melanin; which is responsible for the 
pigment in skin. (Porter et al 2011) 
 
1.2.2 Anatomy of normal skin 
In order to understand skin cancer in depth, the structure of skin; largest organ in the body 
is studied in detail. The skin comprises of two main layers, the dermis and the epidermis. 
The different parts of the body have a varied thickness of dermis and epidermis, ranging 
from 2mm to 4mm.  
 
 
 
 
 
 
 
 
 
 
Figure 1.2: Anatomy of skin, highlighting the epidermis and dermis layer (Bliss, 2010) 
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1.2.2.1 Epidermis 
The epidermis layer of the skin is made up of three types of cells, squamous cells, basal 
cells and melanocytes. Majority of the epidermis is made up of the squamous cells, the 
basal cells are round and found at the bottom of the squamous cells, melanocytes produces 
a pigment called melanin and is found between basal cells and other cells (Samarasinghe 
and Madan, 2012). 
1.2.2.2 Dermis 
The dermis of the skin layer consists of skin vasculature, nerves, sebaceous; which 
produces sebum to keep the skin moist and waterproof and sweat glands. The collagen 
and elastin in the skin gives it strength and elasticity.  
1.2.3 Causes of Skin Cancer 
Skin is the largest organ of the body and acts as a barrier and protects the body not only 
physically but also chemically against the harmful environmental agents such as 
pathogens ultraviolet radiation, chemicals and temperature fluctuations (Penta, 
Somashekar and Meeran, 2017). Most skin cancers are caused by exposure to sun, 
accounting for 65% of skin cancer across the world (Armstrong and Kricker, 1995). 
Factors that can contribute to cause skin cancer include family history, personal 
characteristics such as blue eyes, fair and/or red hair, sun exposure, atypical mole 
syndrome or socioeconomic status. (Heistein and Acharya, 2018) 
1.2.4 Symptoms 
Skin cancer melanoma can develop in any part of the body; especially those areas which 
have been exposed to sun like face, legs and arms.  One of the first symptoms include 
change in a normal looking skin, whether colour, texture, development of new mole or 
changes to previous mole such as discharge, discolouration or rapid increase in size.  
1.2.5 Diagnosis 
An initial assessment is carried out using the ABCDE rule by the clinician’s unaided eye, 
see table 1.2 (Skin cancer: Types, diagnosis and prevention, 2013). To limit human error, 
false negative cases and to improve efficacy, new detection and diagnostic techniques 
such as skin surface microscopes are used which allows improved visualisation of lesion. 
(Kittler H, 2002) Other advanced development diagnostic techniques include; MEDS, an 
automated melanoma diagnosis system used to analyse different measurement and 
characteristics of patient lesions to produce effective diagnosis. (Sboner et al., 2003) 
Other diagnostic techniques used for detection of skin cancer include, X ray, computed 
tomography scan or positron emission tomography scan, ultrasonography of regional 
lymph nodes or lymph node biopsy (Board, 2018).  
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Table 1.2: The ABCDE rule used by clinicians to carry out initial assessment 
Asymmetry The mole has an irregular shape 
Border The border of the mole is irregular or has jagged edges 
Colour There is a mix of colours in the mole 
Diameter The diameter of the mole is greater than 7mm 
Evolution The mole has changed size shape or colour 
 
1.2.6 Stages  
The stages of skin cancer melanoma is dependent on the thickness of the cancer and its 
spread. The thicker the cancer and/or the more it has spread the serious the cancer and 
therefore the higher the stage (Clinic, 2018). Letters T N M are used to determine the 
severity; (Kaufman, 2018). 
• T is used for the extent of the tumour. Ulceration is the breakdown of the skin 
over the tumour which  is not visible to the naked eye but is visible under a 
microscope during a biopsy is a sign of danger. In general, the thicker the tumour 
the harder it is to cure the cancer. (Kaufman, 2018). 
• N is used for lymph node. Lymph nodes contain white blood cells, if melanoma 
is spread to nearby lymph nodes than its an advanced stage cancer (Kaufman, 
2018). 
• M is metastasis, cancer that has spread to other organs or distant lymph nodes is 
very dangerous (Kaufman, 2018). 
Skin cancer melanoma is divided into four stages, see table below. (nhs.uk, 2017) 
Table 1.3: Different stages of skin cancer melanoma 
Stage Description 
Stage 0 Melanoma is on surface of skin (nhs.uk, 2017) 
Stage 1 
1A: The melanoma is less than 1mm thick (nhs.uk, 
2017) 
1B: The melanoma is 1-2mm thick or less than 1mm 
(nhs.uk, 2017) 
Stage 2 
2A: The melanoma is 2-4mm thick or its 1-2mm thick 
and ulcerated (nhs.uk, 2017) 
2B: the melanoma is thicker than 4mm or its 2-4mm 
thick and ulcerated (nhs.uk, 2017) 
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2C: The melanoma is thicker than 4mm and ulcerated 
(nhs.uk, 2017) 
Stage 3 
3A: The melanoma has spread to 1 to 3 nearby lymph 
nodes, but they are not enlarged, the melanoma is not 
ulcerated and has not spread (nhs.uk, 2017) 
3B: The melanoma has spread to 1 to 3 nearby lymph 
nodes and is ulcerated but they are not enlarged, or the 
melanoma is enlarged but not ulcerated and has spread 
to 1 to 3 nearby lymph nodes, or the melanoma has not 
spread to nearby (nhs.uk, 2017) 
3C: The melanoma is ulcerated and enlarged and has 
spread to 1 to 3 nearby lymph nodes, or it has spread 
into 4 or more lymph nodes nearby (nhs.uk, 2017) 
Stage 4 The melanoma cells have spread to other parts of the 
body such as brain or lungs or to other parts of the body 
(nhs.uk, 2017) 
 
1.2.7 Treatment 
The treatment varies for every patient, depending on the type of cancer, the stage of 
cancer; as to how far it has spread or the size and general health. Surgery is the main 
treatment for skin cancer melanoma. (nhs.uk, 2017). Currently there are five different 
types of standard treatment options that includes surgery, chemotherapy, radiation 
therapy, immunotherapy and targeted therapy; available to treat skin cancer patients 
(Board, 2019). 
1.2.7.1 Surgery 
The primary treatment option for all stage of melanoma is to remove tumour via surgery. 
In order to remove the melanoma tumour, a wide local excision is carried out. In some 
cases, skin grafting; which is taking part of skin from another part of the body and 
replacing it on top of the skin that is being removed; is done to cover the wound caused 
by surgery (Board, 2019). 
The surgery is carried out to improve patient’s quality of life (Board, 2019). In some 
cases, patients are given chemotherapy post the surgery to kill any cancer cells that are 
left, whereas in other cases chemotherapy is given to lower the risk of the cancer 
returning, this is also known as adjuvant therapy (Board, 2019). 
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1.2.7.2 Chemotherapy  
Chemotherapy is a treatment for cancer, that uses drugs to stop the growth of cancer cells 
either by killing them or stopping their growth (Board, 2019). Chemotherapy is 
administered in various ways such as via injection to veins or muscles, or placed directly 
to the organ or cerebrospinal fluid or body cavity, or directly to the arm or leg where the 
cancer is in. The administration of chemotherapy is dependent on type and stage of cancer 
(Board, 2019). Dacarbazine also known as DTIC, is one of the alkylating agents used to 
treat skin cancer, by sticking to cancer cell and damaging the DNA. Other drugs include; 
Temozolomide, Nab-paclitaxel, cisplatin, vinblastine etc. Vinblastine is a vinca alkaloid 
that binds to tublin and inhibit assembly of microtubules causing M phase cell cycle 
arrest. 
1.2.7.3 Radiation Therapy 
A high energy x-rays or other types of radiation is used in a radiation therapy to treat 
cancer by either killing the cancer cells or stopping their growth (Board, 2019). There are 
two types of radiation therapy: 
• Internal Radiation therapy, which uses needles or catheters sealed with radioactive 
substance to be placed inside or near the cancer (Board, 2019). 
• External Radiation therapy; sends radiation towards the cancer while the body is 
inside the machine (Board, 2019). 
The type of radiation given is dependent on type and stage of cancer. 
1.2.7.4 Immunotherapy 
Immunotherapy is another type of standard treatment for cancer which uses patient’s 
immune system to fight cancer. The body’s natural defence is boosted by substances made 
by the body or in the laboratory to fight against cancer (Board, 2019). Currently there are 
four types of immunotherapy being used to treat melanoma; immune checkpoint inhibitor 
therapy, Interferon, Interleukin-2 (il-2) and tumour necrosis factor (TNF) (Board, 2019). 
The common immunotherapy currently in use is Nivolumab and Ipilimumab, this is used 
when cancer cannot be removed by surgery. (30) 
1.2.7.5 Targeted Therapy 
Targeted therapy is used to treat cancer with drugs that only target the cancer cells and 
cause less harm to normal cells in comparison to chemotherapy and radiotherapy (Board, 
2019). Some of the targeted therapy being used to treat melanoma include; signal 
transduction inhibitor, oncolytic virus therapy and angiogenesis inhibitors.   
1.2.7.6 New Treatment in Clinical Trials  
New treatments are currently being studied to find a treatment for skin cancer, to improve 
quality of life of patients. One of the main treatments under study is the vaccine therapy 
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for stage 3 melanoma; which is to use of substances for immune system to respond to 
tumour and kill it (Board, 2019). 
1.3 Medicinal Plants as source of anticancer drugs 
The use of medicinal plants for treating diseases goes back to one of the traditional 
methods of healing. Since 1980 to 2002, 69% of the approved anticancer drugs have 
been developed from naturals sources (Cragg and Newman, 2007). The use of allopathy, 
using drugs to cause an opposite effect to the symptom (definition of allopathy in English 
by oxford dictionaries, 2017), in treating cancer brings along complications and adverse 
effects due to toxic levels. The demand for naturally derived drugs from medicinal plants 
is increasing day by day due to low levels of toxicity in comparison to current 
therapies (Greenwell and Rahman, 2015)    
Vinca alkaloids are a group of compounds derived from a medicinal plant and the second 
most common therapy drug used to treat cancer. Four vinca alkaloids namely, vinblastine, 
vincristine, vindesine and vinorelbine, act as anti- tumour and antiluekemic agents. They 
are extracted from the pink periwinkle plant, Catharanthus roseus G. Though they are 
classified as alkaloid based on the formation and bonding of oxygen, carbon, hydrogen 
and nitrogen, some of the alkaloids do not pose alkaline properties. Vinblastine, a vinca 
alkaloid binds to tublin, inhibit assembly of microtubules causing M phase specific cell 
cycle arrest, hence stopping the development and growth of cancerous cells. It was 
discovered in 1950 for the first time and are known as cancer fighter’s due to its cytotoxic 
effects. Recently in 2008 another alkaloid has been developed and is used in Europe for 
treatment called vinflunine. These alkaloids are not only used for treating cancer but are 
also used in treating high blood pressure and diabetes due to hypoglycaemic properties. 
The mechanism of action of vinca alkaloids involve interaction with tubulin and 
disruption of microtubules. . (Moudi et al., 2013). The vinca alkaloid bind to the site of 
tubulin separate from taxannes disrupting microtubule congregation leading to metaphase 
arrest hence stopping the growth of cells. They interact with the mitotic spindles stopping 
the replication and growth of cancer cells leading to the death in process of division. 
Though the stop the growth of cell, but the side effect is that they vinblastine causes 
toxicity in white blood cells. (Moudi et al., 2013). Although these are found to be the 
most effective cancer cell treatment as the replication of cells is stopped instantly after 
interaction, but they also affect normal healthy cells. These alkaloids are generally used 
in combination for the purpose of treating cancer. (DeGregorio and Wiebe, 1999).  
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Taxol also known as Paclitaxel is derived from a natural product called Pacific yew tree, 
is used to treat several types of cancer by blocking the growth of the cells. (Weaver 2014). 
Chlormethine also known as Mustargen is an alkylating agent used to treat cancer. This 
was discovered accidently in 1940’s when mustard gas was released and inhaled by 
people, it was noticed that the white blood cells count has decreased, hence was further 
investigated and it is currently being used to treat lymphatic cancer called Hodgkin’s 
lymphoma (Singh et al., 2018). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Structure of Taxol 
 
1.3.1 Selection of plants:  
In house plants were selected on the basis of literature review, traditional uses and 
previous research carried out. The selection of plants is based on exploring research 
papers about their properties and traditional use to treat cancer by searching on various 
sites; PubMed, Google Scholar, Science Direct, and Medline. The review of plants looked 
at papers from various years by searching various keywords; such as name of the plant, 
cancer, treatment, traditional use, medicinal plants and properties. The inclusion criteria 
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was looking at traditional use of the plants within a timespan of around 30-40 years 
focusing on treatment and medicinal use. The excluding criteria was to ignore diagnostic 
or causative use of the plants.  The study looked at specific properties of each plants 
mainly focusing on anti cancer activity. Some properties of the plants with respect to 
cancer can be seen in the table 1.4. These plants were identified by a qualified taxonomist 
and the voucher specimens of these plants were submitted to the Bangladesh National 
Herbarium.   
Table 1.4: Name of plants, the family and properties 
Name of Plant Family Properties Source 
Agropyron 
cristatumWheatgrass 
Poaceae Anticancer (Gore, 2017) 
 
Proline 
Botanicals  
Andrographis 
paniculata Kalmegh 
Acanthaceae Antitumor and 
antimetastic (Yue et al., 
2019) 
 
Bangladesh 
Angelica archangelica 
Angelica 
Apiaceae Antitumor (Oliveira et al., 
2019) 
 
Proline 
Botanicals  
Apium graveolens 
Celery 
Apiaceae Antitumor (Hazafa et al., 
2019) 
Proline 
Botanicals  
Borage root Starflower Boraginaceae Anti-
inflammatory  (Akinbo et 
al., 2018) 
 
Proline 
Botanicals  
Agathosma, Buchu 
Leaf 
Rutaceae Anti-inflammatory 
(Drugs.com, 2019) 
Proline 
Botanicals  
Equisetum arvense 
Horsetail 
Equisetum Antioxidant and 
antiproliferative 
(Četojević-Simin et al., 
2010) 
 
Proline 
Botanicals  
Feronia limonia Wood 
Apple 
Rutaceae Antioxidant 
(Thirugnanasampandan 
and David 2014) 
Bangladesh 
Glycyrrhiza glabra 
Liquorice 
Fabacea Antiproliferative (Gioti et 
al., 2019) 
 
Proline 
Botanicals  
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Hemidesmus indicus 
Anantmool 
Apocynaceae Anticancer (Turrini et al., 
2018) 
 
Bangladesh 
Hypericum perforatum 
St John’s Wort 
Hypericaceae  Anxiolytic (Howe et al., 
2016) 
Proline 
Botanicals  
Hyssopus officinalis 
Hyssop 
Lamiaceae Antioxidant and 
antiproliferative (Nile, 
Nile and Keum, 2017) 
 
Proline 
Botanicals  
Lavandula Lavender Lamiaceae Antioxidant antibacterial 
and antiproliferative 
(Nunes et al., 2016) 
Proline 
Botanicals  
Matricia recutita 
Chamomile 
Asteraceae Antioxidant and anti 
cancer (Al-Dabbagh et al., 
2019) 
Proline 
Botanicals  
Melissa officinalis 
Lemon Balm 
Lamiaceae Anxiolytic (Howe et al., 
2016) 
Proline 
Botanicals  
Rosa gallica Rose Rosaceae Anti-inflammatory and 
antioxidant (Lee et al., 
2018) 
Proline 
Botanicals  
Rosmarinus Rosemary Lamiaceae Antitumor (Pérez-
Sánchez et al., 2019) 
Proline 
Botanicals  
Salix alba White 
Willow 
Salicaceae Antitoxic and antitumor 
(Aksinenko et al., 2015) 
Proline 
Botanicals  
Salvia Sage Lamiaceae Antiproliferative (Jiang, 
Zhang and Rupasinghe, 
2017) 
 antioxidant (GARCIA et 
al., 2016) 
Proline 
Botanicals  
Swertia cirayita 
Felworts 
Gentianaceaea Antiproliferative (Wang 
et al., 2018) 
Bangladesh 
Tilia x europea Lime Malvaceae Anxiolytic and anti 
fungal (Howe et al., 
2016) 
Proline 
Botanicals  
Turnera diffusa 
Damiana 
Passifloraceae Antibacterial antioxidant 
and anticancer (Avelino-
Flores et al., 2015) 
Proline 
Botanicals  
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Tussilago farfara, 
Coltsfoot 
Asteraceae Anticancer and 
antimicrobial (Lee et al., 
2019) 
Proline 
Botanicals  
Valeriana, Valerian Caprifoliaceae Antitumor (Honma et al., 
2019) 
Proline 
Botanicals  
Viola tricolor 
Heartsease 
Violaceae Anticancer (Sadeghnia et 
al., 2014) 
Proline 
Botanicals  
Zingiber officinale wild 
Ginger 
Zingiberaceae Anti leukemic, 
anticancer, Kalantari et 
al., 2019) 
antioxidant and 
antimicrobial (Rahimi 
Babasheikhali, Rahgozar 
and Mohammadi, 2019)  
 
Bangladesh 
 
A recent study shows the use of two traditional medicinal plants in Srilanka that pose 
anticancer properties. Zingiber officinale commonly known as wild ginger is used as an 
anticancer agent to prepare traditional medicine for treatment of gastrointestinal, liver 
and oesophageal cancer (Singh, 2007). Hemidesmus indicus, commonly known as 
Indian Sarsaprilla is also used as an anticancer agent as it poses poly herbal properties 
Eleonora Turrini and Manuele, 2018).  
1.4 Aim 
The overall aim of this study is to investigate selected traditional medicinal plant extracts 
against human skin cancer melanoma cell line A375 and mice skin cancer melanoma cell 
line B16. 
1.4.1 Objectives 
To prepare chloroform and methanol extracts using Soxhlet extraction. 
To maintain human skin cancer melanoma cell line A375 and mice skin cancer melanoma 
cell line B16. 
To treat A375 and B16 cell line with different concentrations of different plant extracts. 
To test cell viability of A375 and B16 cell line using colorimetric assay, MTT. 
. 
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Chapter 2: Materials and Methods  
2.1 Plant Materials 
In house plants, available in the lab, were screened for anti-cancer activity during this 
study. Majority of the plants were purchased from commercial suppliers including Proline 
Botanicals (currently Herb in a Bottle). Some plants were also collected by a PhD student 
Holly Siddique from Bangladesh and voucher specimens of these plants were kept in the 
Bangladesh national Herbarium.  
 
2.2 Experimental Design 
Plants were extracted sequentially with chloroform and methanol using Soxhlet 
apparatus. These were screened against human and mouse cell lines from different origins 
to analyse cell viability using colorimetric assay.  
 
Table 2.1: Cell lines used in this study and related disease 
 Cell Lines Cell Types (Organ) Disease Source 
Mice A375 Epithelial (skin) Malignant 
Melanoma 
(Atcc.org, 
2018) 
 
   
   
   
   
   
   
   
   
   
   
   
   
   
 H
um
an
 
B16 Mixture of spindle 
shaped epithelial cells 
(skin) 
Melanoma (Lgcstandards-
atcc.org, 2018) 
DU145 Epithelial (prostate, 
derived from 
metastatic site: brain) 
Prostate Carcinoma (Lgcstandards-
atcc.org, 2018) 
 
MCF-7 Epithelial (mammary 
gland, breast, derived 
from metastatic site: 
pleural effusion) 
Breast 
Adenocarcinoma 
(Lgcstandards-
atcc.org, 2018) 
 
 
2.3 Plant Extraction 
Soxhlet extraction, the most common method of extracting compounds from natural 
products, involves a solvent to extract the desired compounds from the solid material, 
therefore is known as a form of continuous solid liquid extraction.  
Dried plant materials were crushed using a mortar and pestle to give larger surface area 
before undergoing soxhlet extraction. The solid materials (plant samples; 1-2 gm) were 
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placed in thimble before being placed in the main chamber of the extractor and the solvent 
(chloroform or methanol; 50-100 ml) was placed in the distilled flask at a temperature of 
4°C. The plant sample was extracted by heat reflux for 120min. The extracts were dried 
off using a rotary vapour evaporation and stored at 4°C before use.  
These extracts were used for cell viability study against different cancer cell lines.  
 
2.4 Plant Sample Preparation 
Using a weighing scale 10mg of crude extracts were transferred to labelled vials and 
stored at 4°C. Crude extracts were dissolved in DMSO to give a stock solution of 
40mg/ml and further diluted to the required starting concentration using complete growth 
medium when required.  
2.5 Cell Lines and Growth Conditions  
The complete medium also known as growth medium was prepared in a sterile flow hood 
and stored at 4C for all the cell lines. Human skin melanoma; A375, Rat skin melanoma; 
B16 and Prostate cancer; DU145 cells were cultured in RPMI 1640 cell culture media, 
supplemented with 10% (v/v) foetal bovine serum (FBS) and 1% (v/v) 
penicillin/streptomycin. All the cell lines were grown in humidified incubator at 37°C 
with 5% CO2. These cells were provided by School of Pharmacy, University College 
London.  
2.6 Cell culture 
The cell lines were grown in complete growth medium until 80-90% confluent to be used. 
In this assay the nature of the cells was adherent. The medium was discarded, and the 
cells were washed with PBS solution. 1ml trypsin was added to the cell culture flask and 
incubated for 5min for cells to be suspended. The cells were viewed under microscope to 
check for dissociation, once fully dissociated, 10ml fresh medium was added. The cells 
were then centrifuged at 300*g for 5min. Then the medium was removed, and cells were 
resuspended in 5ml fresh medium. 0.025ml cell sample was mixed with 0.475ml trypan 
blue in a 1.5ml Eppendorf tube, 0.1ml of this solution was loaded onto the Neubauer cell 
counting chamber to count the cells. The cells were seeded into a clear 96 well cell culture 
plate at the optimum seeding density for all cell lines (1x10 cells/ml). The cells were 
incubated for 24h at 37°C and 5% CO2 before the treatment was added. The cell lines 
used were maintained in Complete Medium and every 48h the media was refreshed. The 
cells were passaged when 80-90% confluence.   
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2.7 Comparison between different Assays  
Table 2.2: Comparison between different types of assays to determine cell viability. 
 SRB  XTT MTT 
Principle  SRB (Sulforhodamine B) 
assay is a colorimetric 
assay, used to determine 
cytotoxicity. The SRB 
assay consists of four 
stages; the preparation of 
treatment followed by 
incubation of cells with 
treatment, cell fixation, 
SRB staining and 
absorbance 
measurement. (Orellana 
and Kasinski, 2018) 
XTT assay is a 
colorimetric assay 
used to determine 
cell proliferation. 
(Sigma-Aldrich, 
2018) 
 
  
MTT (3-(4,5-dimethythiazol-
2-yl)-2,5-diphenyl 
tetrazolium bromide) assay is 
a colorimetric assay, used to 
determine cell viability. 
(Ogbole et al., 2018) 
 
 
Mechanism  SRB (Sulforhodamine B) 
assay is a colorimetric 
assay, which in acidic 
conditions binds to the 
protein but under basic 
conditions can be 
extracted (Orellana and 
Kasinski, 2018) 
 
 The colourless or 
slightly yellow 
XTT dye is reduced 
to brightly orange 
soluble formazan 
derivative. (Wang, 
Yu and Wickliffe, 
2011) (Berridge, 
Herst and Tan, 
2005) 
 
 
 
 
The yellow MTT dye 
(tetrazolium) is reduced by the 
succinate dehydrogenase to 
form a purple coloured 
insoluble compound known as 
formazan. The amount of 
formazan produced is 
proportional to the number of 
viable cells. (George et al., 
2010) 
DMSO (dimethyl sulfoxide), a 
solubilising solution is added 
to dissolve the purple 
formazan containing cells 
which is measured by 
spectrophotometry.  
Uses  It is used to 
measure cell 
proliferation, 
It is used to measure cell 
viability and proliferation. 
(Ogbole et al., 2018) 
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cytotoxicity and 
apoptosis. (Wang, 
Yu and Wickliffe, 
2011) 
Limitation  It is a long process  
Expensive  
Expensive  
 
2.8 MTT Assay  
MTT (3-(4,5-dimethythiazol-2-yl)-2,5-diphenyl tetrazolium bromide) assay is a 
colorimetric assay, used to determine cell viability of plant extracts (Ogbole et al., 2018). 
The yellow MTT dye (tetrazolium) is reduced by the succinate dehydrogenase to form a 
purple coloured insoluble compound known as formazan. The amount of formazan 
produced is proportional to the number of viable cells (George et al., 2010). DMSO 
(dimethyl sulfoxide), a solubilising solution is added to dissolve the purple formazan 
containing cells which is measured by spectrophotometry. A comparison of a few cell 
viability assay was carried out as can be seen in table 2.3 above. MTT assay was selected 
for cell viability assay due to its cost effectiveness and quicker results. 
The cells were seeded in a 96 well plate with a density of 1 x 105 cells/ml in a 100ul 
complete growth medium and incubated for 24h at 37C and 5% CO2. The cells were 
treated with 100ul of 1:20 diluted extracts to give concentrations of 500, 250, 125, 62.5 
and 31.25µg/ml along with vehicle control and positive control (doxorubicin) and 
incubated for 4h, 24h and 48h at 37C and 5% CO2.After  24h incubation 10ul of yellow 
MTT reagent from 5mg/ml stock solution was added to each well and the 96 well plates 
were wrapped around in foil to maintain MTT sensitivity to light and incubated for 2h to 
4h at 37C and 5%CO2. The precipitated crystals were dissolved in 100ul of DMSO. The 
absorbance was read using a microplate reader at a wavelength of 570nm. Every 
experiment included a set of vehicle control (cells+ media+ DMSO) and negative control 
(cells + media). The experiment was performed using technical replicates of 4 on the plate 
(Figure 3). 
A comparison of different colorimetric assays; SRB, XTT and MTT was carried out for 
determination of cell viability as can be seen in Table 6. MTT (3-(4,5-dimethythiazol-2-
yl)-2,5-diphenyl tetrazolium bromide)) assay was carried out to determine the cell 
viability of plant extracts on rat and human skin cancer melanoma cell lines A375 and 
B16, respectively. MTT assay involves fewer steps; hence is not complicated, uses fewer 
materials; therefore, is cheaper and doesn’t have any radioactive waste disposal. On the 
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contrary SRB assay is limited to manual or semiautomatic screening and the process is 
very complicated and XTT assay is very expensive. (Riss et al., 2018) 
2.8.1 Vehicle  
Traditionally water is used to dissolve plant extract, but complete aqueous dissolution 
was not possible. Therefore DMSO (Dimethyl sulfoxide) was used as a vehicle control to 
dissolve all the controls and plant extracts. DMSO was used as it is a routinely used 
solvent in laboratories. (Rodríguez-Burford C, 2003) 
2.8.2 Control 
Positive controls were used to show that the assay is working as well as to account the 
effects of vehicle control. Positive control was tested against both the cell lines to 
determine cell viability using MTT assay. The positive control selected is already in use 
to treat cancer, therefore showed that the system worked well.  
Doxorubicin is generally used as a positive control to determine cell viability or cell 
proliferation via MTT assay. It is a chemotherapeutic agent that has been in use to treat 
cancer since 1960s. (Johnson-Arbor and Dubey, 2018). All the 52 extracts from 26 plants 
screened against A375 and B16 at a concentration of 500µg/ml (as this showed the least 
cell viability), were compared to Doxorubicin; the positive control as can be seen in figure 
30 to figure 33.  
 
2.8a 96 well plate template  
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2.9 Statistical Analysis 
The results were expressed as means and ±standard deviation of the technical replicates 
(n=1; 4 technical replicates on the plate) followed by calculating %cell viability using the 
formula below. One way analysis of variance (ANOVA) was performed for comparing 
the data. All statistical analysis were performed using GraphPad Prism 4.02. The 
differences were accepted as statistically significant at ***p<0.001, **p<0.01 and 
p<0.05.  
% Cell Viability = (absorbance for treated cells / absorbance of control cells) * 100 
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Chapter 3: Results 
To investigate the cytotoxic effects of medicinal plants on human malignant melanoma 
cell line A375 and rat melanoma cell line B16, a total of 26 plants were extracted with 
chloroform and methanol using Soxhlet extraction. 52 extracts from 26 plants were 
screened against A375 and B16 using a colorimetric assay, MTT to determine cell 
viability. The absorbance was read using a microplate reader at a wavelength of 570nm.  
3.1 Determination of Cell Viability 
52 extracts from 26 plants at five different concentrations (31.25, 62.5, l25, 250, 
500µg/ml) were screened against A375 and B16 using a colorimetric assay, MTT to 
determine cell viability.  The vehicle control DMSO was also tested to ensure the cell 
viability in extract treated cells is not compromised. It can be seen that each plant 
treatment showed a different degree of cell death as the concentration increased. Almost 
all treatment achieved an IC50 at different concentration. Methanol extracts have overall 
shown a decrease in cell viability as per its high polar and strong attractive forces nature.  
3.1.1 Overview of Results obtained 
The results obtained from this study shows that activity of all plant extracts is 
concentration dependant. Except, Hemidesmus indicus, all other plants have shown cell 
viability less than 50% when treated with 500µg/ml across both cell lines as can be seen 
in figures 3.1-3.8; which shows the presence of an active phytochemical agent. However, 
almost all plant extracts have shown cell viability more than 75% when treated with 
31.25µg/ml across both cell lines. Most extracts have shown stronger cytotoxic activity 
against B16 than A375. The percentage cell viability decreased as the concentration of 
plant extracts increase, hence resulting in negative correlation. Methanol extracts tend to 
show lower % cell viability in comparison to chloroform such as Andrographis 
paniculata methanol extracts show a % cell viability of 0.2% in both cell lines; b16 and 
A375, whereas chloroform extracts showed around 10% and 0.3% cell viability in A375 
and B16 respectively as can be seen in figure 3.6. Overall methanol extracts have shown 
the least % cell viability in comparison to chloroform extract.  
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Figure3.1:Determination of Cell Viability.  % Cell Viability of Zingiber officinale Ginger 
(a) Methanol extract on A375 human melanoma, (b) Chloroform extract on A375 human 
melanoma, (c) Methanol extract on B16 rat melanoma and (d) Chloroform extract on B16 
rat melanoma, via MTT assay 24hr after treatment at different concentrations. Samples 
were compared using one way ANOVA. Error bars indicated mean ± SD, (n=1; 4 
technical replicates on the plate), ***p<0.001, **P<0.01, *P<0.05, in comparison to 
vehicle control DMSO at a final concentration of 0.1%.  
Zingiber officnale commonly known as ginger pose many medical properties such as 
antibacterial, antifungal anti-inflammatory and anticancer (Mbaveng and Kute, 2017). 
Zingiber officinale chloroform and methanol extract have shown a decrease in percentage 
cell viability as the concentration increases as can be seen above. Both the extracts have 
shown relatively low % cell viability on both cell lines; however, methanol extract has 
shown the least cell viability of 25% on rat melanoma B16 cell line at 500µg/ml 
concentration as can be seen in figure c.  
% Cell Viability of Plant Zingiber officinale Wild Ginger 
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Figure 3.2: Determination of Cell Viability.  % Cell Viability of Hemidesmus indicus 
Anantmool (a) Methanol extract on A375 human melanoma, (b) Chloroform extract on 
A375 human melanoma, (c) Methanol extract on B16 rat melanoma and (d) Chloroform 
extract on B16 rat melanoma, via MTT assay 24hr after treatment at different 
concentrations. Samples were compared using one way ANOVA. Error bars indicated 
mean ± SD, (n=1; 4 technical replicates on the plate), ***p<0.001, **P<0.01, *P<0.05, 
in comparison to vehicle control DMSO at a final concentration of 0.1%.  
Hemidesmus indicus chloroform and methanol extract have shown a decrease in 
percentage cell viability as the concentration increases. The methanol extract has shown 
the least % cell viability of 75% on B16 at 500µg/ml as can be depicted in figure c. 
However, these extracts have not had much impact on the cell viability of both the cell 
lines showing not much significance. Only 25% cell death is induced at max, that could 
be caused due to other factors, hence it is observed that Hemidesmus doesn’t contain 
active phytochemicals. 
% Cell Viability of Plant Hemidesmus indicus Anantmool 
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Figure 3.3: Determination of Cell Viability.  % Cell Viability of Tussilago farfara 
Coltsfoot (a) Methanol extract on A375 human melanoma, (b) Chloroform extract on 
A375 human melanoma, (c) Methanol extract on B16 rat melanoma and (d) Chloroform 
extract on B16 rat melanoma, via MTT assay 24hr after treatment at different 
concentrations. Samples were compared using one way ANOVA. Error bars indicated 
mean ± SD, (n=1; 4 technical replicates on the plate), ***p<0.001, **P<0.01, *P<0.05, 
in comparison to vehicle control DMSO at a final concentration of 0.1%.  
Overall Tussilago farfara chloroform and methanol extract have shown a decrease in 
percentage cell viability as the concentration increases. Both the extracts have shown 
relatively low % cell viability on both cell lines; however, Chloroform extract has shown 
the least cell viability on rat melanoma B16 cell line at 500µg/ml concentration as can be 
seen in figure d.  
 
  
% Cell Viability of Plant Tussilago farfara Coltsfoot 
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Figure 3.4: Determination of Cell Viability.  % Cell Viability of Andrographis paniculata 
Kalmegh (a) Methanol extract on A375 human melanoma, (b) Chloroform extract on 
A375 human melanoma, (c) Methanol extract on B16 rat melanoma and (d) Chloroform 
extract on B16 rat melanoma, via MTT assay 24hr after treatment at different 
concentrations. Samples were compared using one way ANOVA. Error bars indicated 
mean ± SD, (n=1; 4 technical replicates on the plate), ***p<0.001, **P<0.01, *P<0.05, 
in comparison to vehicle control DMSO at a final concentration of 0.1%.  
Overall Andrographis paniculata chloroform and methanol extract have shown a 
decrease in percentage cell viability as the concentration increases. Both the extracts have 
shown relatively low % cell viability on both cell lines; however, methanol extract has 
shown the least cell viability of 1% on rat melanoma B16 cell line at 500µg/ml 
concentration as can be seen in figure c. The methanol extracts show a less than 50% cell 
viability at 62.5µg/ml and onwards in comparison to chloroform extracts which shows 
almost 75%. 
  
% Cell Viability of Plant Andrographis paniculata Kalmegh 
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Figure 3.5: Determination of Cell Viability.  % Cell Viability of Equisetum arvense 
Horsetail (a) Methanol extract on A375 human melanoma, (b) Chloroform extract on 
A375 human melanoma, (c) Methanol extract on B16 rat melanoma and (d) Chloroform 
extract on B16 rat melanoma, via MTT assay 24hr after treatment at different 
concentrations. Samples were compared using one way ANOVA. Error bars indicated 
mean ± SD, (n=1; 4 technical replicates on the plate), ***p<0.001, **P<0.01, *P<0.05, 
in comparison to vehicle control DMSO at a final concentration of 0.1%.  
Equisetum arvense chloroform and methanol extract have shown a decrease in percentage 
cell viability as the concentration increases. Both the extracts have shown relatively 
low % cell viability on both cell lines; however, methanol extract has shown the least cell 
viability of 1% on rat melanoma B16 cell line at 500µg/ml concentration as can be seen 
in figure c. These extracts resulted in significant results, as both extracts on both cell lines 
shows %cell viability of less than 25%. It can be seen above that there is an active 
phytochemical compound present in these extracts that can be a future potential as its 
shows the least cell viability at the least concentration. 
 
 
% Cell Viability of Plant Equisetum arvense Horsetail 
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Figure 3.6: Determination of Cell Viability.  % Cell Viability of Melissa officinalis 
Lemon Balm  (a) Methanol extract on A375 human melanoma, (b) Chloroform extract 
on A375 human melanoma, (c) Methanol extract on B16 rat melanoma and (d) 
Chloroform extract on B16 rat melanoma, via MTT assay 24hr after treatment at different 
concentrations. Samples were compared using one way ANOVA. Error bars indicated 
mean ± SD, (n=1; 4 technical replicates on the plate), ***p<0.001, **P<0.01, *P<0.05, 
in comparison to vehicle control DMSO at a final concentration of 0.1%.  
Overall Melissa officinalis chloroform and methanol extract have shown a decrease in 
percentage cell viability as the concentration increases. The methanol extract has shown 
the least % cell viability about 2% on A375and B16 at 500µg/ml as can be depicted in 
figure a and c respectively.  
 
 
 
 
 
% Cell Viability of Plant Melissa officinalis Lemon Balm 
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3.2 Comparison with Positive Control 
 The 52 extracts from 26 different plants screened against A375 and B16 were compared 
with the positive control Doxorubicin (1uM) at the highest concentration of 500µg/ml 
showing the least % cell viability.  
                
   
Figure 3.7: Determination of cell viability of positive control doxorubicin vs methanol 
extracts at concentration of 500µg/ml on A375 human melanoma via MTT assay 24hr 
after treatment at different concentrations. Samples were compared using one-way 
ANOVA. Error bars indicated mean ± SD, (n=1; 4 technical replicates on the plate), 
***p<0.001, **P<0.01, *P<0.05, in comparison to vehicle control DMSO at a final 
concentration of 0.1%.  
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Figure 3.8: Determination of cell viability of positive control doxorubicin vs chloroform 
extracts at concentration of 500µg/ml on A375 human melanoma via MTT assay 24hr 
after treatment at different concentrations. Samples were compared using one-way 
ANOVA. Error bars indicated mean ± SD, (n=1; 4 technical replicates on the plate), 
***p<0.001, **P<0.01, *P<0.05, in comparison to vehicle control DMSO at a final 
concentration of 0.1%.  
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Figure 3.9: Determination of cell viability of positive control doxorubicin vs methanol 
extracts at concentration of 500µg/ml on B16 rat melanoma via MTT assay 24hr after 
treatment at different concentrations. Samples were compared using one-way ANOVA. 
Error bars indicated mean ± SD, (n=1; 4 technical replicates on the plate), ***p<0.001, 
**P<0.01, *P<0.05, in comparison to vehicle control DMSO at a final concentration of 
0.1%.  
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Figure 3.10: Determination of cell viability of positive control doxorubicin vs chloroform 
extracts at concentration of 500µg/ml on B16 rat melanoma via MTT assay 24hr after 
treatment at different concentrations. Samples were compared using one-way ANOVA. 
Error bars indicated mean ± SD, (n=1; 4 technical replicates on the plate), ***p<0.001, 
**P<0.01, *P<0.05, in comparison to vehicle control DMSO at a final concentration of 
0.1%.  
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Chapter 4: Discussion 
 
Cancer is the second leading cause of death across the globe and is responsible for every 
sixth death in the world (Who.int, 2019). It has resulted in approximately 9.6 million 
deaths in 2018, which is an increase of nearly 10% since 2015 (8.8 million). (Who.int, 
2019). This is not only affecting the quality of life of patients but also creates a significant 
burden on global economy.  
An intervention to find a treatment for cancer has become the utmost focus of research 
due to the impact on global economy and increase in number of cancer deaths. Natural 
products have been in use to treat cancer for over 40 years (Demain and Vaishnav, 2010). 
Therefore, the purpose of this study was aimed at understanding the role of medicinal 
plants in treatment of cancer and to lay foundations for future work as well as to assess if 
the constituent of the plant could be used as a possible treatment option for cancer 
patients.  
Cancer is the second leading cause of mortality worldwide (2018). The survival rate of 
cancer patient is increasing due to use of chemotherapy and radiotherapy but this lease to 
several toxic effects (Qamar, Rehman and Chauhan, 2019). This has led to search for new 
anticancer agents that are more effective and cause less side effects. recent study’s 
findings show anticancer drugs derived from medicinal plant to pose minimum cytotoxic 
values in a dose dependent MTT assay as they inhibit tumour growth. (Qamar, Rehman 
and Chauhan, 2019). Hence there has been an incline towards finding active 
phytochemicals in medicinal plants in search for anticancer drugs with minimal side 
effects.  
This study evaluated 52 extracts from medicinal plants (Table 1 in methods) on A375 and 
B16 cell lines using MTT. Overall most of the plant extracts have shown a decrease in 
cell viability against both the cancer cell line A375 and B16. It Is also very evident by 
looking at the figures in result section that as the concentration increases the % cell 
viability decrease, hence, %cell viability is inversely proportional to the concentration 
and shows negative correlation. Hemidesmus indicus has shown anticancer properties in 
previous studies (Turrini et al., 2018). For example, a 2011 study has shown to induce 
cell death at all concentrations against Jukrat cells. (Fimognari et al., 2011). However, 
this study presented doesn’t show significant decrease in cell viability in both the cell 
lines against Hemidesmus indicus. Despite increasing the concentration of dose, the % 
cell viability is more than or around 75% just about inducing cell death in 25% of cell, 
that could be possibly caused due to other possible factors such as natural death, 
contamination or technical errors.  
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Plants such as Equisetum arvense Horsetail and Andographis paniculata Kalmegh 
extracts have shown a massive decrease in cell viability against both the cell lines as can 
be seen in figures 7 and 6 respectively. Equisetum arvense component EA1 has shown 
decrease in cell viability of A549, lung carcinoma using MTT and has manifested 
cytotoxicity (Mohammed, Paray and Rather, 2017). A recent study shows, that Equisetum 
arvense extracts can be potentially used as chemo preventive agent or coadjuvant 
chemotherapy due its nature of preventing chromosomal damage in induced mice. (Koue 
et al., 2017). A 2014 study resulted in 1.09µg/ml IC50 of Equisetum arvense however 
this study shows an IC50 0f 0.56µg/ml, which means that Equisetum arvense is more 
potent to skin cancer cell line A375.  Andrographis paniculata has shown anti tumor, anti 
metastic and immunomodulatory properties in esophagael cancer animal models, by 
supressing growth of cells and increasing cell death without causing severe side effect 
like other chemotherapeutics (Yue et al., 2019). A recent study also shows that 
Andrographis paniculata plays a major role in treatment for prostate cancer by causing 
DNA damage post inhibiting PCa (Forestier-Roman et al., 2019). Hence the results 
obtained from this and previous study shows pharmacological significance and need to 
be further investigated in search for potential anticancer agent.  
It is observed that Melissa officinalis Lemon Balm extracts out of the 52 extracts were 
highly lethal to both the cell lines A375 and B16 (figure6). This shows that this compound 
contains bioactive substance and if studied in detail could provide active compounds that 
pose antitumor or antiproliferative properties. Melissa officinalis is currently in use in the 
market to treat a disease called herpes. Herpes is a viral condition, in which blisters are 
developed around different parts of the body majorly around lip area, the anti-viral cream 
made of Melissa officinalis is used to treat that by peeling of the dead skin. Looking at 
the theory of use of Melissa officinalis to treat herpes, it can potentially be used to treat 
skin cancer formed above the skin, following the same process of applying it over the 
affected area and letting it peel off as a dead skin. However, further investigation needs 
to be carried out before it comes in the market.  
In comparison to the positive control Doxorubicin, Swertia cirayita Felworts both extracts 
chloroform and methanol have shown the most significance against both the cell lines 
A375 and B16 with the p value ranging between 0.01 and 0.5. Though the % cell viability 
of Swertia cirayita has decreased for both the extracts against both the cell lines but is 
above 50%, hence it is seen that although the cell viability drops with administration of 
Swertia cirayita viability, but it might be due to other contributing factors. 
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Figures 3.7-3.10 shows a comparison between the positive control Doxorubicin and both 
plant extracts on A375and B16. Overall it is observed that Hemidesmus indicus and 
Zingiber officinalis shows significantly higher %cell viability on both cell lines in 
comparison to positive control. Tussilago farfara shows a varied %cell viability across 
both cell lines; with low % cell viability of chloroform extract on B16 of 4%  whereas a 
high % cell viability of methanol extract of  35% on A375. On the other hand, the other 
3 plants Andrographis paniculata, Equisetum arvense and Melissa officinalis both 
extracts shows a significant decrease in % cell viability in comparison to positive control 
Doxorubicin on both A375 and B16 cell lines. 
 
Future Work 
Continuing with this research, it is wise to screen these extracts at a larger scale by 
carrying out other assays then MTT such as SRB assay to determine cell viability in order 
to ensure quality of data as well as gathered data. Other than cell viability, other factors 
such as morphological changes in the shape and size of cell, protein content should be 
observed using techniques like electron microscopy, western blotting and Elisa.  
One of the other things would be to repeat the experiments carried out number of times 
to ensure the quality of results and data obtained. This will not only qualify the data, but 
the data produced will be more reliable and accurate as well as discard any human, 
standard or technical errors. Due to time constraints, the assays were carried out at time 
lapse of 24hrs only, the assays can be carried out over a time lapse of 4hrs, 8hrs, 12hrs 
and 48hrs to ensure the exact time of effect of medicinal plant extract cause the viability 
of cells to decrease. This will help to determine the effect of medicinal plant after 
administration hence will be beneficial in deciding the course of action of medications in 
future.  
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